A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)
Clinical trial NCT00044057 · COMPLETED
Trial details
- NCT number
- NCT00044057
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-12-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.